Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Core EBITDA Growth

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -36.0267.63-48.67-10.49286.35

What is the latest Core EBITDA Growth ratio of NGL FINECHEM ?

The latest Core EBITDA Growth ratio of NGL FINECHEM is -36.02 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-36.02
Mar202467.63
Mar2023-48.67
Mar2022-10.49
Mar2021286.35

How is Core EBITDA Growth of NGL FINECHEM Trending?

Years Core EBITDA Growth % Change
Mar2025 -36.02
Negative
Mar2024 67.63
Positive
Mar2023 -48.67
Negative
Mar2022 -10.49
Negative
Mar2021 286.35 -

Other Financial Ratios of NGL FINECHEM


Compare Core EBITDA Growth ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹933.7 Cr 1.1% 4.9% -22.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,804.0 Cr -0.2% 3.6% -7.8% Stock Analytics
DIVIS LABORATORIES ₹170,764.0 Cr -2.4% 9.1% 13.4% Stock Analytics
CIPLA ₹126,807.0 Cr -5.7% 4% 6.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,099.0 Cr -0.3% 1.3% 8.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,707.0 Cr 0.1% 1.2% -2.8% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

1.1%

4.9%

-22.6%

SENSEX

0.3%

3.6%

5.5%


You may also like the below Video Courses